» Articles » PMID: 38369563

Impact of the Diet in the Gut Microbiota After an Inter-species Microbial Transplantation in Fish

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 18
PMID 38369563
Authors
Affiliations
Soon will be listed here.
Abstract

Inter-species microbial transplantations offer the possibility of transferring species-specific microbes and their associated functionality. As a conceptual approach, an intestinal microbiota transplant (IMT) between two marine carnivorous fish species that thrive in different environmental conditions was conducted: from donor Atlantic salmon (Salmo salar) to recipient gilthead seabream (Sparus aurata), after obliterating its basal microbiota with an antibiotic treatment. To confirm that the gut microbiota was able to recover after antibiotics without the influence of the diet, a group of gilthead seabream not submitted to the IMT was kept fasted as an internal control. To assess the effect of the diet after the IMT, two groups of gilthead seabream were respectively fed with their typical diet and with Atlantic salmon diet. At 36 days post-IMT, the gut of the individuals fed with their typical diet was dominated by the feed-associated bacteria, while those fed with the salmon diet had developed a unique microbiota from the convergence of the diet, donor, and recipient microbiota. These results suggested that an intestinal microbiota transplantation may be effective if the basal microbiota from the gut is first cleared and a targeted dietary modification is provided to maintain and enrich the novel bacteria species over time.

Citing Articles

Cichlid fishes are promising underutilized models to investigate helminth-host-microbiome interactions.

Vanhove M, Koblmuller S, Fernandes J, Hahn C, Plusquin M, Kmentova N Front Immunol. 2025; 16:1527184.

PMID: 40018030 PMC: 11864961. DOI: 10.3389/fimmu.2025.1527184.


Beyond Microbial Variability: Disclosing the Functional Redundancy of the Core Gut Microbiota of Farmed Gilthead Sea Bream from a Bayesian Network Perspective.

Moroni F, Naya-Catala F, Hafez A, Domingo-Breton R, Soriano B, Llorens C Microorganisms. 2025; 13(1).

PMID: 39858966 PMC: 11767429. DOI: 10.3390/microorganisms13010198.


Morpho-physiological digestive features of genetically closely related sympatric lacustrine whitefish forms with different feeding habits.

Solovyev M, Shokurova A, Kondakova E, Vasilenko V, Bochkarev N, Kashinskaya E Fish Physiol Biochem. 2025; 51(1):34.

PMID: 39825033 DOI: 10.1007/s10695-024-01440-4.


A review on comparative analysis of marine and freshwater fish gut microbiomes: insights into environmental impact on gut microbiota.

Singh B, Thakur K, Kumari H, Mahajan D, Sharma D, Sharma A FEMS Microbiol Ecol. 2024; 101(1.

PMID: 39719366 PMC: 11730441. DOI: 10.1093/femsec/fiae169.


Comparative study of the gut microbial communities collected by scraping and swabbing in a fish model: a comprehensive guide to promote non-lethal procedures for gut microbial studies.

Ruiz A, Torrecillas S, Kashinskaya E, Andree K, Solovyev M, Gisbert E Front Vet Sci. 2024; 11:1374803.

PMID: 38585300 PMC: 10997143. DOI: 10.3389/fvets.2024.1374803.

References
1.
Valenzuela M, Caruffo M, Herrera Y, Medina D, Coronado M, Feijoo C . Evaluating the Capacity of Human Gut Microorganisms to Colonize the Zebrafish Larvae (). Front Microbiol. 2018; 9:1032. PMC: 5987363. DOI: 10.3389/fmicb.2018.01032. View

2.
Quaranta G, Fancello G, Ianiro G, Graffeo R, Gasbarrini A, Cammarota G . Laboratory handling practice for faecal microbiota transplantation. J Appl Microbiol. 2019; 128(3):893-898. DOI: 10.1111/jam.14522. View

3.
Roeselers G, Mittge E, Stephens W, Parichy D, Cavanaugh C, Guillemin K . Evidence for a core gut microbiota in the zebrafish. ISME J. 2011; 5(10):1595-608. PMC: 3176511. DOI: 10.1038/ismej.2011.38. View

4.
Fehily S, Basnayake C, Wright E, Kamm M . Fecal microbiota transplantation therapy in Crohn's disease: Systematic review. J Gastroenterol Hepatol. 2021; 36(10):2672-2686. DOI: 10.1111/jgh.15598. View

5.
Schoultz I, Keita A . Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function. Cells. 2019; 8(2). PMC: 6407030. DOI: 10.3390/cells8020193. View